Beyond Chemotherapy, PD-1, and HER-2: Novel Targets for Gastric and Esophageal Cancer
Together, gastric cancer and esophageal cancer (EC) possess two of the highest incidence rates amongst all cancers. They exhibit poor prognoses in which the 5-year survival rate is dismal. In addition to cytotoxic chemotherapy, treatment efforts have been geared toward targeting human epidermal grow...
Main Authors: | Ali Zubair Siddiqui, Khaldoun Almhanna |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/17/4322 |
Similar Items
-
The significance of metalloproteinases and their inhibitors in gastric cancer
by: Marta Łukaszewicz-Zając, et al.
Published: (2009-06-01) -
Prognostic value of Dickkopf-1 and ß-catenin expression in advanced gastric cancer
by: Soon Auck Hong, et al.
Published: (2018-05-01) -
Epidemiology, Diagnosis, Staging and Multimodal Therapy of Esophageal and Gastric Tumors
by: Donelle Cummings, et al.
Published: (2021-02-01) -
Clinical value of ELISA detection of serum Exosome and Dickkopf-1 content in patients with gastric cancer
by: Hua-Guo Wang
Published: (2017-02-01) -
The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer
by: Maciej Szmitkowski, et al.
Published: (2012-04-01)